Cargando…

PS183. Effect of electroconvulsive therapy on monoamine oxidase A binding - a preliminary report

Detalles Bibliográficos
Autores principales:	Baldinger-Melich, Pia, James, Gregory M., Hienert, Marius, Cécile, Philippe, Silberbauer, Leo, Wadsak, Wolfgang, Hahn, Andreas, Mitterhauser, Markus, Kasper, Siegfried, Frey, Richard, Lanzenberger, Rupert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616778/ http://dx.doi.org/10.1093/ijnp/pyw043.183

Ejemplares similares

PS186. Light exposure and seasonal variation of the serotonin degrading enzyme monoamine oxidase A in the healthy human brain revealed by PET
por: Hienert, Marius, et al.
Publicado: (2016)

Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy
por: Spies, Marie, et al.
Publicado: (2018)

Changes in White Matter Microstructure After Electroconvulsive Therapy for Treatment-Resistant Depression
por: Gryglewski, Gregor, et al.
Publicado: (2019)

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
por: James, Gregory M., et al.
Publicado: (2017)

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET
por: Lanzenberger, R, et al.
Publicado: (2013)

Effects of Silexan on the Serotonin-1A Receptor and Microstructure of the Human Brain: A Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study with Molecular and Structural Neuroimaging
por: Baldinger, Pia, et al.
Publicado: (2015)

Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis
por: Gryglewski, Gregor, et al.
Publicado: (2019)

Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo
por: Spies, Marie, et al.
Publicado: (2023)

Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression
por: Kautzky, Alexander, et al.
Publicado: (2019)

Correction: Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression
por: Kautzky, Alexander, et al.
Publicado: (2019)

Effects of bilateral sequential theta-burst stimulation on 5-HT(1A) receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial
por: Murgaš, Matej, et al.
Publicado: (2023)

Exploring the Impact of BDNF Val66Met Genotype on Serotonin Transporter and Serotonin-1A Receptor Binding
por: Kraus, Christoph, et al.
Publicado: (2014)

Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR
por: Silberbauer, Leo R., et al.
Publicado: (2019)

High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People
por: Kranz, Georg S., et al.
Publicado: (2015)

PS87. An update on prediction of treatment outcome in treatment resistant depression
por: Kautzky, Alexander, et al.
Publicado: (2016)

Striatal dopaminergic alterations in Tourette’s syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies
por: Hienert, Marius, et al.
Publicado: (2018)

Brain glucose uptake during transcranial direct current stimulation measured with functional [(18)F]FDG-PET
por: Kraus, Christoph, et al.
Publicado: (2019)

The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning
por: Kautzky, A, et al.
Publicado: (2017)

The Impact of Theta-Burst Stimulation on Cortical GABA and Glutamate in Treatment-Resistant Depression: A Surface-Based MRSI Analysis Approach
por: Spurny-Dworak, Benjamin, et al.
Publicado: (2022)

Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity
por: Hahn, Andreas, et al.
Publicado: (2017)

Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET
por: Sigurdardottir, Helen L., et al.
Publicado: (2015)

Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography
por: Spies, Marie, et al.
Publicado: (2017)

Topologically Guided Prioritization of Candidate Gene Transcripts Coexpressed with the 5-HT(1A) Receptor by Combining In Vivo PET and Allen Human Brain Atlas Data
por: Unterholzner, Jakob, et al.
Publicado: (2020)

Making Sense of Connectivity
por: Hahn, Andreas, et al.
Publicado: (2018)

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)

PT550. Interregional Correlations of SERT in Attention Deficit/Hyperactivity Disorder compared to Healthy Controls; Investigated with PET and [(11)C]DASB
por: Vanicek, Thomas, et al.
Publicado: (2016)

Effect of MAOA DNA Methylation on Human in Vivo Protein Expression Measured by [(11)C]harmine Positron Emission Tomography
por: Handschuh, Patricia A, et al.
Publicado: (2022)

Association of Protein Distribution and Gene Expression Revealed by PET and Post-Mortem Quantification in the Serotonergic System of the Human Brain
por: Komorowski, A., et al.
Publicado: (2017)

Sex Matters: A Multivariate Pattern Analysis of Sex- and Gender-Related Neuroanatomical Differences in Cis- and Transgender Individuals Using Structural Magnetic Resonance Imaging
por: Baldinger-Melich, Pia, et al.
Publicado: (2020)

Association of dopamine D(2/3) receptor binding potential measured using PET and [(11)C]-(+)-PHNO with post-mortem DRD(2/3) gene expression in the human brain
por: Komorowski, Arkadiusz, et al.
Publicado: (2020)

ABUSE OF MONOAMINE OXIDASE INHIBITORS
por: Ananth, Jambur, et al.
Publicado: (1995)

[(18)F]FMeNER-D2: Reliable fully-automated synthesis for visualization of the norepinephrine transporter
por: Rami-Mark, Christina, et al.
Publicado: (2013)

PS168. Hybrid PET/MR imaging of serotonin transporter occupancy and brain activation to elucidate the mechanism of action of selective serotonin reuptake inhibitors
por: Gryglewski, G, et al.
Publicado: (2016)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
por: Naoi, Makoto, et al.
Publicado: (2022)

ABCB1 variants and sex affect serotonin transporter occupancy in the brain
por: Silberbauer, Leo R., et al.
Publicado: (2022)

Preparation and First Preclinical Evaluation of [(18)F]FE@SNAP: A Potential PET Tracer for the Melanin-Concentrating Hormone Receptor-1 (MCHR1)
por: Philippe, Cécile, et al.
Publicado: (2013)

Amphetamine Derivatives as Monoamine Oxidase Inhibitors
por: Reyes-Parada, Miguel, et al.
Publicado: (2020)

Parameters for Irreversible Inactivation of Monoamine Oxidase
por: Ramsay, Rona R., et al.
Publicado: (2020)

Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue
por: Haj Ahmed, Wiem, et al.
Publicado: (2020)

Reliable set-up for in-loop (11)C-carboxylations using Grignard reactions for the preparation of [carbonyl-(11)C]WAY-100635 and [(11)C]-(+)-PHNO()
por: Rami-Mark, Christina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5jdpb1hfi34fl5aspt8cgdrcqu